Status:
UNKNOWN
Deep Brain Stimulation Lead Localization After Implantation
Lead Sponsor:
Tsinghua University
Conditions:
Parkinson Disease
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Deep brain stimulation (DBS) is an effective treatment for a variety of neurological and psychiatric disorders, with more than 200,000 patients implanted with DBS devices worldwide. Parkinson's diseas...
Eligibility Criteria
Inclusion
- Parkinson's disease patients with DBS devices, DBS implanted for at least 1 month.
- Ability to tolerate DBS turn-off for at least 30 minutes.
- DBS devices do not contain the ferromagnetic material.
- The patients can fully understand the content of the trial and sign the informed consent form.
- Able to comply to the requirements of this study.
Exclusion
- Presence of other concomitant diseases that have or require implantation of pacemakers, defibrillators, cochlear implants, or other neurostimulation devices.
- Patients who are abnormally sensitive to temperature or allergic to heat.
- Patients with severe psychiatric disorders or cognitive impairment.
Key Trial Info
Start Date :
December 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06196242
Start Date
December 10 2023
End Date
December 1 2025
Last Update
January 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Engineering Research Center of Neuromodulation
Beijing, Beijing Municipality, China, 100084